4/A: Viemed Healthcare CFO Trae Fitzgerald Amends SEC Filing After Stock Unit Vesting
SEC Form 4/A Filing
Viemed Healthcare's Chief Financial Officer, Trae Fitzgerald, amended a previous SEC filing to reflect the withholding of shares for tax obligations related to the vesting of restricted stock units.
Summary
- Trae Fitzgerald, the Chief Financial Officer of Viemed Healthcare, filed an amendment to a previous SEC Form 4.
- The amendment reflects the withholding of 1,843 common shares to cover tax liabilities associated with the vesting of 5,405 restricted stock units (RSUs) on January 18, 2025.
- The original filing was made on January 22, 2025, and this amendment clarifies the tax withholding.
- The price per share used for the tax calculation was $8.15, based on the market closing price on January 17, 2025.
- After the transaction, Fitzgerald directly owns 76,161 common shares.
Sentiment
Score: 7
Explanation: The document is a routine SEC filing related to executive compensation. It does not indicate any positive or negative sentiment, but is a normal part of business operations.
Industry Context
This filing is a routine disclosure related to executive compensation and is common for publicly traded companies. It reflects the standard practice of withholding shares to cover tax liabilities when restricted stock units vest.
Comparison to Industry Standards
- The vesting of restricted stock units and the subsequent tax withholding are standard practices in executive compensation across publicly traded companies.
- Many companies use a similar approach to manage tax obligations related to equity-based compensation.
- The specific number of shares withheld and the vesting schedule are specific to Viemed Healthcare's compensation plan, but the overall process is consistent with industry norms.
- Companies like ResMed, AdaptHealth, and Lincare also use similar equity compensation plans for their executives.
Stakeholder Impact
- The transaction has a minor impact on the total number of outstanding shares due to the tax withholding.
- The filing provides transparency to shareholders regarding executive compensation.
Key Dates
| Date | Description |
|---|---|
| 01/18/2022 | Restricted Stock Units (RSUs) granted to reporting person, which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| 01/17/2025 | Date of market closing price used to calculate tax withholding. |
| 01/18/2025 | Date of restricted stock unit vesting and tax withholding. |
| 01/22/2025 | Date of original Form 4 filing. |
| 01/23/2025 | Date of amended Form 4/A filing. |
Keywords
SEC Filing, Form 4, Viemed Healthcare, Restricted Stock Units, RSU, Tax Withholding, Beneficial Ownership, Trae Fitzgerald, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.